4P-Pharma

4P-Pharma is a clinical-stage biotech company that develops regenerative active drugs and therapies. Its focus lies in creating disease-modifying treatments for serious, previously untreatable conditions with high unmet medical needs. The company partners with academic and private institutions, translating scientific discoveries into potential medical solutions.

Founded in 2014 by Revital Rattenbach, 4P-Pharma originated from her seasoned entrepreneurial background in biotech. Rattenbach established the company to address severe diseases through drug regeneration, aiming to bridge the gap between scientific research and clinical application for conditions lacking effective treatments.

4P-Pharma targets patients suffering from severe diseases with currently no adequate therapeutic options. Its long-term vision centers on transforming science into medicine, developing innovative therapies to significantly improve patient outcomes. The company often employs a co-risk co-share model, reflecting a collaborative approach to its mission.